Clovis Oncology Inc EBIT margin
¿Qué es el EBIT margin de Clovis Oncology Inc?
El EBIT margin de Clovis Oncology Inc es -161.75%
¿Cuál es la definición de EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin de compañías en Sector Health Care en NASDAQ en comparadas con Clovis Oncology Inc
Empresas con ebit margin similar a Clovis Oncology Inc
- W Resources Plc tiene EBIT margin de -164.36%
- Haydale Graphene Industries plc tiene EBIT margin de -163.70%
- Nektar Therapeutics tiene EBIT margin de -163.64%
- Nicholas tiene EBIT margin de -162.88%
- SenSen Networks tiene EBIT margin de -162.60%
- Kiadis Pharma N.V tiene EBIT margin de -161.82%
- Clovis Oncology Inc tiene EBIT margin de -161.75%
- co.don AG tiene EBIT margin de -161.62%
- Noida Toll Bridge tiene EBIT margin de -161.17%
- Xcel Brands Inc tiene EBIT margin de -160.69%
- Durect Corp tiene EBIT margin de -160.60%
- Petros Pharmaceuticals tiene EBIT margin de -159.30%
- Xelpmoc Design and Tech tiene EBIT margin de -159.13%